Quarterly report pursuant to Section 13 or 15(d)

Accrued expenses and other current liabilities

v3.24.1.1.u2
Accrued expenses and other current liabilities
3 Months Ended
Mar. 31, 2024
Accrued expenses and other current liabilities  
Accrued expenses and other current liabilities

Note 10 — Accrued expenses and other current liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

​

​

​

​

​

​

​

​

​

March 31, 

​

December 31, 

​

    

2024

    

2023

Accrued clinical and development expenditure

​

$

12,049

​

$

12,351

Accrued employee expenses

​

​

6,248

​

​

13,226

VAT payable

​

​

—

​

​

1,398

Other accrued expenditure

​

​

4,113

​

​

3,277

Other

​

 

640

​

 

51

​

​

$

23,050

​

$

30,303

​